CLASS II Device recall · Reported 5 Feb 2020 · FDA Enforcement Report

VitreQ BF Blunt Needles-.D51 GITN recalled by Vitreq Bv

Vitreq Bv is recalling VitreQ BF Blunt Needles-.D51 GITN: 8719214221164 VitreQ BF Brush Needles-.D52, distributed nationwide in the US. The recall was initiated on 17 Dec 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0847-2020
FDA event ID
84661
Recalling firm
Vitreq Bv, Vierpolders, N/A
Classification
Class II
Status
Terminated
Recall initiated
17 Dec 2019
FDA classified
24 Jan 2020
Reported
5 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

17 Dec 2019Recall initiated by company
24 Jan 2020Classified by FDA+38 days
5 Feb 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microscopic tears of the sterile pouch may compromise sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

(1)VitreQ 25G BF Blunt Needles-BF25.D51 GITN: 8719214221164 (2) VitreQ 25G BF Brush Needles-BF25.D52 GTIN: 8719214221188

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is VitreQ BF Blunt Needles-.D51 GITN: 8719214221164 VitreQ BF Brush Needles-.D52 recalled?

Yes. Vitreq Bv recalled VitreQ BF Blunt Needles-.D51 GITN: 8719214221164 VitreQ BF Brush Needles-.D52 on 17 Dec 2019. The recall is Class II and its status is Terminated. Recall number Z-0847-2020.

Why was it recalled?

Microscopic tears of the sterile pouch may compromise sterility

Which lots are affected?

All lots

Where was it sold?

Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Vitreq Bv

All 16

Other Syringes & Needles recalls

All 1,060